#CSF1R
Nousiainen et al. in the Pietiäinen Lab at the University of Helsinki map neuroblastoma's immune landscape, finding sparse leukocytes (median 1.8% of cells) dominated by macrophages that co-express CD40, CSF1R and CD163, suggesting targets for macrophage-directed immunotherapy.
bioRxiv (Cancer Biology)
www.biorxiv.org
November 14, 2026 at 12:22 AM
Do mouse embryos make blood only in the yolk sac?

MIXER tissue at the maternal-fetal interface in mice is a distinct early hematopoietic niche, containing abundant CSF1R+ erythro-myeloid progenitors and a unique CD4+ CSF1R− eEMPROR population.

#StemCells

doi.org/10.1038/s41590-026-02683-4
The maternal-fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors.
Nature Immunology
jclub.com.au
November 11, 2026 at 11:49 PM
the fda just approved pimicotinib, a csf1r kinase inhibitor, for symptomatic tenosynovial giant cell tumor.

another example of how understanding disease biology and selecting the right molecular target can translate into a new therapeutic option.

www.fda.gov/drugs/cancer...
FDA approves pimicotinib for symptomatic tenosynovial giant cell tumor
FDA approved pimicotinib, a kinase inhibitor, for adults with symptomatic tenosynovial giant cell tumor. Learn more.
www.fda.gov
November 11, 2026 at 10:52 AM
CSF1R inhibition during cranial radiotherapy reshapes the immune environment and glial dynamics #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-11316756/latest
October 30, 2026 at 2:03 PM
Thrilled to share that our team’s latest research has been published back-to-back in @NatImmunol! 🔬👇

These two companion papers reveal a fundamental shift in our understanding of macrophage origins across embryonic development and adult life. (1/5)

www.nature.com/articles/s41...
The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors - Nature Immunology
Jain et al. identify a unique extraembryonic hematopoietic niche at the maternal–fetal interface that is distinct from the yolk sac and is capable of producing CD4+CSF1R− erythro-myeloid progenitors.
www.nature.com
October 28, 2026 at 5:35 PM
Publication 2: While looking for EMPROR cells during development, we found a unique extraembryonic hematopoietic niche at the maternal-fetal interface (MIXER tissue) that harbors progenitors (eEMPROR cells) completely separate from the yolk sac. (3/5)

www.nature.com/articles/s41...
The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors - Nature Immunology
Jain et al. identify a unique extraembryonic hematopoietic niche at the maternal–fetal interface that is distinct from the yolk sac and is capable of producing CD4+CSF1R− erythro-myeloid progenitors.
www.nature.com
October 28, 2026 at 5:35 PM
CD206 doesn't mark a specialized phagocyte, though. CD206+ cells are selectively spared by CSF1R inhibition while the rest of the early population is depleted. Something about the fissure niche supports them independently of canonical CSF1R signaling.

🧵6/8
October 15, 2026 at 4:31 AM
#RUNX2 helps bone-removing cells work. In mouse and cell studies, it activated a newly identified RNA, LncRNA-ROD, which bound QKI and protected Csf1r #mRNA from breakdown. Mice lacking this RNA showed less #bone resorption around teeth and delayed eruption.👇
www.nature.com/articles/s41...
October 8, 2026 at 7:01 AM
Recent research from Dr. Jessica Rosin’s lab at @dmcbrainhealth.bsky.social uncovered how colony-stimulating factor 1 receptor (#CSF1R)-expressing immune cells help guide the formation of bones, teeth, and facial structures during #EmbryonicDevelopment.

🧫 https://bit.ly/3T9CPbm
October 2, 2026 at 2:02 PM
Engineering an inhibitor-resistant human CSF1R variant for microglia replacement rupress.org/jem/article/...
rupress.org
September 30, 2026 at 7:43 PM
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia: The American Journal of Human Genetics www.cell.com/ajhg/fulltex...
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia
Microglia are CNS-resident macrophages that scavenge debris and regulate immune responses. Proliferation and development of macrophages, including microglia, requires Colony Stimulating Factor 1 Recep...
www.cell.com
September 30, 2026 at 7:03 PM
We're in love with our September issue cover! This stunning cover is from an article by the Rosin lab showing how CSF1R signaling impacts not only immune cells but also musculoskeletal development.

Check out the article here:
www.sciencedirect.com/science/arti...
September 25, 2026 at 5:27 PM
New research from Dr. Jessica Rosin’s lab shows that CSF1R-expressing immune cells help shape bones, teeth, the skull & facial muscles during development.

Blocking CSF1R in pregnant mice led to changes across these tissues, highlighting how cells surrounding a structure can influence how it forms.
Beyond immunity: The hidden role of immune cells in early development - Djavad Mowafaghian Centre for Brain Health | DMCBH
When we think about the immune system, we often think about its role in fighting infections and protecting us from disease. But some immune cells have
www.centreforbrainhealth.ca
September 26, 2026 at 12:18 AM
Dual Immunoliposome Targeting of PD-L1 and CSF1R affects T-Cell readouts in tumor-conditioned co-cultures: An In Vitro Study in Glioblastoma and Medulloblastoma https://www.biorxiv.org/content/10.64898/2026.09.16.751417v1
September 23, 2026 at 1:15 AM
Dual Immunoliposome Targeting of PD-L1 and CSF1R affects T-Cell readouts in tumor-conditioned co-cultures: An In Vitro Study in Glioblastoma and Medulloblastoma https://www.biorxiv.org/content/10.64898/2026.09.16.751417v1
September 23, 2026 at 1:15 AM
#WEHI researchers developed #Partita, a high-density mouse genome-wide #CRISPRa library (263,460 sgRNAs), mapping #cancer dependencies, Irx5-driven venetoclax resistance, and in vivo MYC-synergistic oncogenes (Runx2/Runx3/Csf1r). 🐭🤖 #ScienceAdvances2026 #DrugResistance #InVivoScreening
September 22, 2026 at 6:04 AM
ONJCRI, WEHI and Genentech researchers used a new CRISPR guide RNA library (Partita) and discovered that:
➡️ Switching on the Irx5 gene allowed cancer cells to survive venetoclax
️➡️ Runx2, Runx3, and Csf1r genes accelerate MYC-driven lymphoma

📘 https://ow.ly/XmsJ50ZO8xW
#CRISPRActivation #Lymphoma
September 21, 2026 at 12:00 AM
High Frequency of CSF1R Expression in Histiocytosis www.ovid.com/10.1097/PAI....
High Frequency of CSF1R Expression in... : Applied Immunohistochemistry & Molecular Morphology
Abstract was not provided for this article.
www.ovid.com
September 18, 2026 at 2:00 AM
Targeting IGF2BP3-driven CSF1/CSF1R signaling disrupts the positive feedback loop between tumor cells and macrophages and inhibits HCC progression

Life sciences · Ji et al.
doi.org/10.1016/j.lfs.2026.124681
#RNAsky #RNAmods
Targeting IGF2BP3-driven CSF1/CSF1R signaling disrupts the positive feedback loop between tumor cells and macrophages and inhibits HCC progression
Life sciences · Ji X, Zhang L, Zhu X, He J, Ju Y, Jin C, Ma W, Kong X, Guo H, Yu D, Zhao K.
doi.org
September 17, 2026 at 1:20 PM
Lukasz Milanowski, Josiane Souza, Mara Lucia Schmitz Ferreira Santos, Helio G Teive, John K Fink, Jennifer Orthmann-Murphy, Kaley Arnold, Jarosław Dulski, CSF1R‐RD Study Group, and Zbigniew K Wszolek
Colony-stimulating factor 1 receptor-related disorder: Clinical variability of biallelic variants
Biallelic colony-stimulating factor 1 receptor (CSF1R) variants are a major cause of early-onset CSF1R-related disorder (CSF1R-RD), although fewer than 30 cases have been reported and genotype-phenotype correlations remain unclear. The aim of this study was to characterize the clinical, radiological, and genetic features of patients with brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). Six patients with biallelic CSF1R variants underwent detailed clinical, neurological,...
onlinelibrary.wiley.com
September 8, 2026 at 10:00 AM
Notably, #CSF1 levels across tissues closely correlated with macrophage numbers. Blocking #CSF1 strongly depleted macrophages across cardiac and skeletal muscles, whereas loss of IL-34, the alternative #CSF1R ligand, had no effect.
September 5, 2026 at 1:25 PM